Pfizer could soon launch a multi-billion dollar bid for immunotherapy rivals Bristol-Myers Squibb. But moves into new fields of innovation and digital tech – such as Roche’s buyout of Flatiron - are ...

Across 3,600 miles of highway, a Rivian R1T owner proved that while charging is no longer the "Achilles' heel" of EV travel, ...

Nusrat Fateh Ali Khan's poignant ghazal-qawwali unexpectedly mirrors the trajectory of the Indian Left, capturing its initial ...

Bristol-Myers Squibb's flurry of dealmaking has continued with en expansion of its partnership with BridgeBio on drugs targeting SHP2, in the hope of combining them with its cancer immunotherapy ...

Drs Harrington and Gibson’s annual review of cardiovascular medicine: ACS guidelines, antiplatelet management, GLP-1s, and ...

With that, here are two dividend stocks to consider scooping up right now.

Battle Of Galwan teaser has been released on the occasion of Salman Khan's birthday. Here's our detailed trailer review!

Iovance Biotherapeutics targets significant market expansion, with lung cancer representing a $10B U.S. peak sales ...

Omeros transitions from a distressed microcap to a small-cap following a transformative Novo Nordisk deal and FDA approval of ...

The second trailer of Prabhas' The Raja Saab has received a significantly better response from the audience, thus boosting its box office potential.

The MAH BEd CET registration procedure is anticipated to begin on January 1, 2026, by the State Common Entrance Test Cell.

According to DataM Intelligence, the global cell and gene therapy market reached a value of US$13.90 billion in 2024 and is projected to expand significantly to US$105.83 billion by 2033, registering ...